Shareholders may not want to ignore the US$8.4m worth sales made by AbbVie Inc. (NYSE:ABBV) insiders this past year
yahoo.com
news
2022-10-18 11:00:51

While AbbVie Inc. (NYSE:ABBV) shareholders have enjoyed a good week with stock up 4.4%, they need remain vigilant. Although prices were relatively low, insiders chose to sell US$8.4m worth of stock in the past 12 months. This could be a sign of impending weakness.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

View our latest analysis for AbbVie

AbbVie Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider sale was by the Independent Director, Roxanne Austin, for US$8.
